Effects of repeated doses of enalapril on renal function in man.
Open Access
- 1 March 1985
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 19 (3) , 353-361
- https://doi.org/10.1111/j.1365-2125.1985.tb02654.x
Abstract
Ten healthy subjects received 10 mg oral enalapril (MK 421) daily for a period of 8 days. Renal clearances of electrolytes, urate and phosphate were monitored and factored for glomerular filtration rate, as measured by creatinine clearance, with particular emphasis on the first and eighth day of treatment. Apart from a fall of around 10% in creatinine clearance between 1-2 h on both days 1 and 8, GFR remained unchanged throughout the study. Fractional sodium excretion increased in a biphasic manner by approximately 50% over control between 1-2 h and 4-8 h on day 1. Significant chloruresis (+39.0 +/- 12.9%) and kaluresis (+26.5 +/- 10.3%) occurred between 4-8 h. Urinary pH increased between 0-1 h (+0.29 +/- 0.12; P less than 0.05), and between 4-8 h (+0.50 +/- 0.08; P less than 0.01). The biphasic saluretic effect was also seen between 1-2 h and 4-8 h on day 8. Enalapril caused significant increases in urate and phosphate excretion on day 8 of therapy. There was a biphasic increase in fractional urate excretion at 1-2 h (+28.1 +/- 6.9%; P less than 0.05) and at 4-8 h (+21.0 +/- 6.0% P less than 0.01). Significant phosphaturia (+36.8 +/- 5.2%; P less than 0.05) was also observed at 4-8 h on day 8. Urinary drug excretion was also biphasic; over the first 2 h the predominant drug form was unchanged enalapril, whilst the peak excretion of the diacid metabolite, enalaprilat, occurred at 4-8 h.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 31 references indexed in Scilit:
- Pharmacokinetics of repeated single oral doses of enalapril maleate (mk‐421) in normal volunteersBiopharmaceutics & Drug Disposition, 1984
- Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary KidneyNew England Journal of Medicine, 1983
- Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertensionThe American Journal of Cardiology, 1982
- Angiotensin Converting Enzyme (ACE) InhibitorsAnnual Review of Pharmacology and Toxicology, 1982
- Angiotensin II and renal excretion of sodium and potassium in unanaesthetized dogsScandinavian Journal of Clinical and Laboratory Investigation, 1982
- Sodium intake and renal responses to captopril in normal man and in essential hypertensionKidney International, 1981
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential HypertensionNew England Journal of Medicine, 1979
- Angiotensin-Converting Enzyme: Vascular Endothelial LocalizationScience, 1976